60 likes | 166 Views
Abhijit Joshi achievements and Milestones<br>
E N D
ABHIJIT JOSHI Achievements and Milestones
Introduction • Veritas Legal has been founded by Abhijit Joshi, a professional with 22 years of experience in the Indian legal industry and a winner of many national and international accolades. • He was the senior partner and chief executive officer (CEO) at AZB & Partners until November 2104. • His key practice areas included mergers and acquisitions, general corporate and commercial law and private client law. • Mr Abhijit Joshi started his journey with merely 15 lawyers at AZB which has now grown into an organization that has over 200 lawyers. • He is an advocate, solicitor and solicitor England and Wales having completing his articles under AmarchandMangaldas managing partner Cyril Shroff in the early nineties.
Achievements and Milestones - • Abhijit Joshi has featured in International Who’s Who Legal as ‘Leading Lawyer for Mergers & Acquisitions 2013’ and ‘Prominent Lawyer in the Franchise Sector’. • He has also been listed by IFLR1000 as ‘Leading Lawyer for Mergers & Acquisitions Leading and Private Equity 2012 & 2013’. • Abhijit is associated with Entrepreneurs Organization, Young Presidents’ organisation and is a member of Legal Practice Division of International Bar Association. • A member of the Law Firm Management Committee of the International Bar Association, Abhijit is also associated with Law Society of England and Wales. • He holds a Bachelor of Law degree from Bombay University.
Achievements and Milestones - • Abhijit Joshihas been involved in some of the major landmark deals, such as the Rs 5,150 crore Tech Mahindra - Satyam Computer Services merger, Usd 2.6 billion Tata -Docomo transaction among many others • Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin Lifesciences for Rs. 671 crore ($103 million) in an all cash deal. • Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates Natasha Sethna and TejasviSaxena. • This is the largest inbound deal in the sterile injectables space in the last two years, after the $1.75 billion acquisition of Strides Arcolab’s subsidiary Agila Specialities by Mylan in 2013.